ALPS ADVISORS INC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 144 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$871,000
-20.4%
172,337
-2.8%
0.01%
-12.5%
Q2 2019$1,094,000
+15.4%
177,379
-13.1%
0.01%
+14.3%
Q1 2019$948,000
+15.5%
204,203
+4.5%
0.01%
+16.7%
Q4 2018$821,000
-11.7%
195,378
+31.7%
0.01%0.0%
Q3 2018$930,000
+8.1%
148,382
+38.7%
0.01%0.0%
Q2 2018$860,000
+22.3%
106,983
+13.5%
0.01%0.0%
Q1 2018$703,000
+51.8%
94,248
+21.0%
0.01%
+100.0%
Q4 2017$463,000
-9.0%
77,867
+12.5%
0.00%
-25.0%
Q3 2017$509,000
+18.4%
69,204
+9.2%
0.00%
+33.3%
Q2 2017$430,000
-24.4%
63,387
+5.2%
0.00%
-25.0%
Q1 2017$569,000
-2.2%
60,265
-10.5%
0.00%0.0%
Q4 2016$582,000
+70.2%
67,319
-14.2%
0.00%0.0%
Q1 2016$342,000
-39.4%
78,505
-14.6%
0.00%
-33.3%
Q4 2015$564,000
-91.0%
91,959
-15.7%
0.01%
-14.3%
Q3 2015$6,239,000
+1109.1%
109,075
+57.8%
0.01%
+75.0%
Q2 2015$516,000
+150.5%
69,122
+100.2%
0.00%
+100.0%
Q1 2015$206,00034,5200.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 17,902,338$135,342,0005.88%
TIGER MANAGEMENT L.L.C. 1,288,454$9,741,0001.91%
Phocas Financial Corp. 1,047,181$7,917,0000.69%
TUDOR INVESTMENT CORP ET AL 2,370,503$17,921,0000.62%
EAM Investors, LLC 553,309$4,183,0000.58%
Baker Brothers Advisors 4,449,797$33,640,0000.34%
TFS CAPITAL LLC 463,740$3,506,0000.33%
FEDERATED HERMES, INC. 13,508,290$102,123,0000.32%
Rotella Capital Management, Inc. 36,473$276,0000.24%
OXFORD ASSET MANAGEMENT LLP 1,103,848$8,351,0000.18%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders